Nature Reviews Drug Discovery
Volume 20 Issue 7, July 2021
An Audience With
COVID-19 vaccine success enables a bolder vision for mRNA cancer vaccines, says BioNTech CEO
Uğur Şahin, an oncologist and mRNA pioneer, discusses his firm’s development plans for cancer vaccines, mRNA-encoded proteins and more.